Your browser doesn't support javascript.
The COVID - AGICT study: COVID-19 and advanced gastro-intestinal cancer surgical treatment. A multicentric Italian study on the SARS-CoV-2 pandemic impact on gastro-intestinal cancers surgical treatment during the 2020. Analysis of perioperative and short-term oncological outcomes.
Giuliani, Giuseppe; Guerra, Francesco; Messinese, Simona; Santelli, Francesco; Salvischiani, Lucia; Esposito, Sofia; Ferraro, Luca; Esposito, Alessandro; De Pastena, Matteo; Rega, Daniela; Delrio, Paolo; La Raja, Carlotta; Spinelli, Antonino; Massaron, Simonetta; De Nardi, Paola; Kauffmann, Emanuele Federico; Boggi, Ugo; Deidda, Simona; Restivo, Angelo; Marano, Alessandra; Borghi, Felice; Piccoli, Micaela; Depalma, Norma; D'Ugo, Stefano; Spampinato, Marcello; Cozzani, Federico; Del Rio, Paolo; Marcellinaro, Rosa; Carlini, Massimo; De Rosa, Raffaele; Scabini, Stefano; Maiello, Fabio; Polastri, Roberto; Turri, Giulia; Pedrazzani, Corrado; Zese, Monica; Parini, Dario; Casaril, Andrea; Moretto, Gianluigi; De Leo, Antonio; Catarci, Marco; Trapani, Renza; Zonta, Sandro; Marsanic, Patrizia; Muratore, Andrea; Di Franco, Gregorio; Morelli, Luca; Coppola, Alessandro; Caputo, Damiano; Andreuccetti, Jacopo.
  • Giuliani G; Department of General and Emergency Surgery, Misericordia Hospital, Azienda Usl Toscana Sud Est. School of Robotic Surgery, Grosseto, Italy.
  • Guerra F; Department of General and Emergency Surgery, Misericordia Hospital, Azienda Usl Toscana Sud Est. School of Robotic Surgery, Grosseto, Italy.
  • Messinese S; Medical Oncology Unit, Misericordia Hospital, Grosseto, Italy.
  • Santelli F; Department of Economics, Business, Mathematics and Statistics (DEAMS), University of Trieste, Trieste, Italy.
  • Salvischiani L; Department of General and Emergency Surgery, Misericordia Hospital, Azienda Usl Toscana Sud Est. School of Robotic Surgery, Grosseto, Italy.
  • Esposito S; Department of General, Emergency Surgery and New Technologies, Baggiovara General Hospital, AOU Modena, Italy.
  • Ferraro L; Division of General and Robotic Surgery, Dipartimento di Scienze della Salute, Università di Milano, ASST Santi Paolo e Carlo, 20142 Milano, Italy.
  • Esposito A; Department of General and Pancreatic Surgery, The Pancreas Institute, University of Verona Hospital Trust, Piazzale L.A. Scuro, 10, 37134, Verona, Italy.
  • De Pastena M; Department of General and Pancreatic Surgery, The Pancreas Institute, University of Verona Hospital Trust, Piazzale L.A. Scuro, 10, 37134, Verona, Italy.
  • Rega D; Colorectal Surgical Oncology, Abdominal Oncology Department, Fondazione Giovanni Pascale IRCCS, Naples, Italy.
  • Delrio P; Colorectal Surgical Oncology, Abdominal Oncology Department, Fondazione Giovanni Pascale IRCCS, Naples, Italy.
  • La Raja C; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072, Milan, Italy; IRCCS Humanitas Research Hospital, Division of Colon and Rectal Surgery, Via Manzoni 56, Rozzano, 20089, Milan, Italy.
  • Spinelli A; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072, Milan, Italy; IRCCS Humanitas Research Hospital, Division of Colon and Rectal Surgery, Via Manzoni 56, Rozzano, 20089, Milan, Italy.
  • Massaron S; Division of Gastrointestinal Surgery, San Raffaele Hospital, Milan, Italy.
  • De Nardi P; Division of Gastrointestinal Surgery, San Raffaele Hospital, Milan, Italy.
  • Kauffmann EF; Division of General and Transplant Surgery, University of Pisa, Pisa, Italy.
  • Boggi U; Division of General and Transplant Surgery, University of Pisa, Pisa, Italy.
  • Deidda S; Department of Surgery, Colorectal Surgery Center, University of Cagliari, Cagliari, Italy.
  • Restivo A; Department of Surgery, Colorectal Surgery Center, University of Cagliari, Cagliari, Italy.
  • Marano A; General and Specialist Surgery Department, Emergency General Surgery Unit, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy.
  • Borghi F; Oncological Surgery, Candiolo Cancer Institute-FPO-IRCCS, Candiolo, 10060, Torino, Italy.
  • Piccoli M; Department of General, Emergency Surgery and New Technologies, Baggiovara General Hospital, AOU Modena, Italy.
  • Depalma N; Department of General Surgery, "Vito Fazzi" Hospital, Piazza Muratore, 1-73100, Lecce, Italy.
  • D'Ugo S; Department of General Surgery, "Vito Fazzi" Hospital, Piazza Muratore, 1-73100, Lecce, Italy.
  • Spampinato M; Department of General Surgery, "Vito Fazzi" Hospital, Piazza Muratore, 1-73100, Lecce, Italy.
  • Cozzani F; General Surgery Unit, Parma University Hospital, Parma, Italy.
  • Del Rio P; General Surgery Unit, Parma University Hospital, Parma, Italy.
  • Marcellinaro R; Department of General Surgery, S. Eugenio Hospital, Piazzale dell'Umanesimo, 10, 00144, Rome, Italy.
  • Carlini M; Department of General Surgery, S. Eugenio Hospital, Piazzale dell'Umanesimo, 10, 00144, Rome, Italy.
  • De Rosa R; Surgical Oncology Surgery, IRCCS Policlinico San Martino, Genoa, Italy.
  • Scabini S; Surgical Oncology Surgery, IRCCS Policlinico San Martino, Genoa, Italy.
  • Maiello F; Department of Surgery - General Surgery Unit, Hospital of Biella, Biella, Italy.
  • Polastri R; Department of Surgery - General Surgery Unit, Hospital of Biella, Biella, Italy.
  • Turri G; Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Unit of General and Hepatobiliary Surgery, University and Hospital Trust of Verona, 37134, Verona, Italy.
  • Pedrazzani C; Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Unit of General and Hepatobiliary Surgery, University and Hospital Trust of Verona, 37134, Verona, Italy.
  • Zese M; Department of General and Urgent Surgery, Santa Maria della Misericordia Hospital, Rovigo, Italy.
  • Parini D; Department of General and Urgent Surgery, Santa Maria della Misericordia Hospital, Rovigo, Italy.
  • Casaril A; Department of Surgery, "Pederzoli" Hospital, Peschiera del Garda, Verona, Italy.
  • Moretto G; Department of Surgery, "Pederzoli" Hospital, Peschiera del Garda, Verona, Italy.
  • De Leo A; General Surgery Unit, Sandro Pertini Hospital, ASL Roma 2, Via dei Monti Tiburtini, 385, 00157, Rome, Italy.
  • Catarci M; General Surgery Unit, Sandro Pertini Hospital, ASL Roma 2, Via dei Monti Tiburtini, 385, 00157, Rome, Italy.
  • Trapani R; Department of General Surgery, Ospedale San Biagio, ASL VCO, Domodossola, Italy.
  • Zonta S; Department of General Surgery, Ospedale San Biagio, ASL VCO, Domodossola, Italy.
  • Marsanic P; Surgical Department, E. Agnelli Hospital, 10064, Pinerolo, Italy.
  • Muratore A; Surgical Department, E. Agnelli Hospital, 10064, Pinerolo, Italy.
  • Di Franco G; General Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Paradisa 2, 56125, Pisa, Italy.
  • Morelli L; General Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Paradisa 2, 56125, Pisa, Italy.
  • Coppola A; Dipartimento di chirurgia, Sapienza Università di Roma, Rome, Italy.
  • Caputo D; Research Unit of Generale Surgery, Department of Medicine and Surgery, University Campus Bio-Medico di Roma, Via Alvaro del Portillo 200, 00128, Rome, Italy; Operative Research Unit of General Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128, Roma
  • Andreuccetti J; Second General Surgery, ASST Spedali Civili di Brescia, Brescia, Italy.
Surg Oncol ; 47: 101907, 2023 Apr.
Article in English | MEDLINE | ID: covidwho-2221394
ABSTRACT

BACKGROUND:

This Italian multicentric retrospective study aimed to investigate the possible changes in outcomes of patients undergoing surgery for gastrointestinal cancers during the COVID-19 pandemic.

METHOD:

Our primary endpoint was to determine whether the pandemic scenario increased the rate of patients with colorectal, gastroesophageal, and pancreatic cancers resected at an advanced stage in 2020 compared to 2019. Considering different cancer staging systems, we divided tumors into early stages and advanced stages, using pathological outcomes. Furthermore, to assess the impact of the COVID-19 pandemic on surgical outcomes, perioperative data of both 2020 and 2019 were also examined.

RESULTS:

Overall, a total of 8250 patients, 4370 (53%) and 3880 (47%) were surgically treated during 2019 and 2020 respectively, in 62 Italian surgical Units. In 2020, the rate of patients treated with an advanced pathological stage was not different compared to 2019 (P = 0.25). Nevertheless, the analysis of quarters revealed that in the second half of 2020 the rate of advanced cancer resected, tented to be higher compared with the same months of 2019 (P = 0.05). During the pandemic year 'Charlson Comorbidity Index score of cancer patients (5.38 ± 2.08 vs 5.28 ± 2.22, P = 0.036), neoadjuvant treatments (23.9% vs. 19.5%, P < 0.001), rate of urgent diagnosis (24.2% vs 20.3%, P < 0.001), colorectal cancer urgent resection (9.4% vs. 7.37, P < 0.001), and the rate of positive nodes on the total nodes resected per surgery increased significantly (7 vs 9% - 2.02 ± 4.21 vs 2.39 ± 5.23, P < 0.001).

CONCLUSIONS:

Although the SARS-CoV-2 pandemic did not influence the pathological stage of colorectal, gastroesophageal, and pancreatic cancers at the time of surgery, our study revealed that the pandemic scenario negatively impacted on several perioperative and post-operative outcomes.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pancreatic Neoplasms / Colorectal Neoplasms / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: Surg Oncol Journal subject: Neoplasms Year: 2023 Document Type: Article Affiliation country: J.suronc.2023.101907

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pancreatic Neoplasms / Colorectal Neoplasms / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: Surg Oncol Journal subject: Neoplasms Year: 2023 Document Type: Article Affiliation country: J.suronc.2023.101907